Robert Kennedy Jr. has announced he will chair President Donald Trump's new commission on vaccine safety. Read More »

A final rule issued by the Department of Health and Human Services allows pharmacies increased flexibility to extend reward and loyalty programs to patients enrolled in government-sponsored programs like Medicare and Medicaid. Read More »

Walgreens has a new partnership to offer customers FedEx dropoff and pickup services at Walgreens locations throughout the country. Read More »

An Illinois-based pharmacy group is leading the charge for an antimicrobial therapy timeout initiative, in response to a joint commission mandate. Read More »

The National Institute of Allergy and Infectious Diseases recently released new guidelines to help health care providers and family members manage and prevent peanut allergies in infants. Read More »

A recent Centers for Disease Control and Prevention report showed the challenges rural health care faces and the need for provider status legislation. Read More »

The 22nd PBMI Annual Drug Benefit Conference is set for March 6-8 in Orlando, Florida. Read More »

Members of the American Pharmacists Association submitted a joint statement to President Donald Trump's administration, asking for an appeal to a recent U.S. Food and Drug Administration decision saying a pharmacist cannot begin to fill a patient’s prescription without a written, valid prescription on hand. Read More »

The FDA has extended the review period for Baricitnib, a new once-a-day drug for rheumatoid arthritis. Read More »

Dealing with the thorny, and often contentious, issue of drug prices is likely to be front and center in the early days of the new Trump administration. Arriving at a solution to curb increasing costs will be a delicate balance for all those with a stake in the issue, according to a leading health economist. Read More »

New data from the Centers for Medicare and Medicaid Services shows that major chain pharmacies such as CVS, Walgreens and Walmart account for over 79 percent of Prescription Drug Plans for the elderly. Read More »

New legislation for Medicare Part B beneficiaries has recently been reintroduced to the Senate to give underserved communities access to pharmacist-provided care. Read More »

New data released by the Department of Health and Human Services shows that adults with disabilities on Medicare continue to save on prescriptions, and that there has been an increase in benefits from last year as a result of the Affordable Care Act. Read More »

The U.S. Food and Drug Administration has approved Vantrelatm, a pain medication designed by Teva Pharmaceutical Ltd., for long-term use in time-released capsules. Read More »

Following recent public reaction to the price of epinephrine auto-injector pens, known as “epi-pens,” and the desire for an affordable alternative, CVS Health intends to market authorized generic version two-packs for $109.99 apiece. Read More »

A recent study has shown that using acetaminophen, an ingredient commonly found in painkillers, over a long period of time leads to an increased risk of hearing loss in adults. Read More »

Mylan CEO Heather Bresch presented at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Read More »

The European Commission has granted Gilead Sciences Inc. marketing authorization for Vemlidy, a drug used in the treatment of people suffering from chronic Hepatitis B infections. Read More »

The U.S. Food and Drug Administration recently approved a license application for Mylan Biotechnology, in collaboration with Biocon, for the use of biosimilar tratuzumab in the treatment of breast cancer. Read More »

Gilead Sciences Inc., has awarded more than $22 million in grants to help fund HIV cure programs. Read More »